High numbers of regulatory T cells (red) — seen here interacting with antigen-presenting cells (blue) — are usually associated with poorer outcomes in cancer. A new MSK study, however, found that a ...

Living with multiple sclerosis (MS) often means dealing with different kinds of pain — some caused by damage to nerves, some by muscle stiffness or spasms, and some related to changes in how the body ...

Memorial Sloan Kettering Cancer Center is partnering with oncology generative AI company Triomics for clinical research. Memorial Sloan Kettering (MSK) Cancer Center's iHub and Clinical Research ...

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...

INDIANAPOLIS — Eager to grow in Indianapolis, Purdue University’s Weldon School of Biomedical Engineering (BME) has announced a plan to launch the Purdue Center for Musculoskeletal Engineering (PCME) ...

The hybrid MSK program integrates virtual care into primary care, aiming to improve outcomes and reduce costs for employers and Taft-Hartley plan sponsors. Medbridge’s Pathways platform is embedded ...

Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 ...

Memorial Sloan Kettering Cancer Center in New York City plans to cut less than 2% of its workforce as part of cost reduction efforts, the organization confirmed to Becker’s. The cancer center faces a ...

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their ...

Memorial Sloan Kettering Cancer Center and United Healthcare announced on July 1 that the entities had reached a multi-year agreement that continues in-network access for UHC’s commercial members. The ...